Trilink Biotechnologies, Part Of Maravai Lifesciences

TriLink BioTechnologies, a subsidiary of Maravai LifeSciences, specializes in the synthesis of nucleic acids, mRNA, and other critical reagents for research, diagnostics, and therapeutic applications. They generate revenue through the sale of custom oligonucleotides, CleanCap® mRNA capping technology, and various other molecular biology products. Founded in 1996, TriLink has played a significant role in advancing genetic research and biotechnology, contributing to the development of vaccines and gene therapies. Their integration into Maravai LifeSciences has expanded their capabilities and market reach, solidifying their position as a key player in the biotech industry.

Recent Posts by Trilink Biotechnologies, Part Of Maravai Lifesciences

1-13 of 13